Caxton Associates LP Chimerix Inc Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.1 - $1.54 $111,766 - $156,473	-101,606 Reduced 59.48%	69,229 $83,000
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.35 $20,315 - $28,587	12,165 Added 7.67%	170,835 $317,000
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.76 $180,587 - $275,370	99,772 Added 169.4%	158,670 $306,000
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $78,923 - $314,515	58,898 New	58,898 $123,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.